These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 238377)

  • 1. Comparison of putative dopamine receptors in blood vessels and the central nervous system.
    Goldberg LI
    Adv Neurol; 1975; 9():53-6. PubMed ID: 238377
    [No Abstract]   [Full Text] [Related]  

  • 2. Attenuation of dopamine-induced renal vasodilation in the dog by phenothiazines.
    Goldberg LI; Yeh BK
    Eur J Pharmacol; 1971 Jun; 15(1):36-40. PubMed ID: 5161338
    [No Abstract]   [Full Text] [Related]  

  • 3. Dopamine antagonism by thioridazine in schizophrenia.
    Meltzer HY; Sachar EJ; Frantz AG
    Biol Psychiatry; 1975 Feb; 10(1):53-7. PubMed ID: 1120175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity.
    Bunney BS; Walters JR; Roth RH; Aghajanian GK
    J Pharmacol Exp Ther; 1973 Jun; 185(3):560-71. PubMed ID: 4576427
    [No Abstract]   [Full Text] [Related]  

  • 5. The action of neuroleptics in rats with altered catecholamine metabolism. 3. The effect of chlorpromazine, haloperidol and thioridazine on the brain dopamine and serotonin contents in the rats pretreated with MAO inhibitors.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):65-83. PubMed ID: 4775865
    [No Abstract]   [Full Text] [Related]  

  • 6. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

  • 7. Dopamine and the pharmacology of schizophrenia: the state of the evidence.
    Matthysse S
    J Psychiatr Res; 1974; 11():107-13. PubMed ID: 4218872
    [No Abstract]   [Full Text] [Related]  

  • 8. Involvement of nigro-striatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine.
    Von Voigtlander PF; Moore KE
    J Pharmacol Exp Ther; 1973 Mar; 184(3):542-52. PubMed ID: 4687219
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine and norepinephrine uptake by rat brain synaptosomes: relative inhibitory potencies of 1- and d-amphetamine and amantadine.
    Thornburg JE; Moore KE
    Res Commun Chem Pathol Pharmacol; 1973 Jan; 5(1):81-9. PubMed ID: 4686111
    [No Abstract]   [Full Text] [Related]  

  • 10. The combined effects of dopamine (DA) and the DA antagonists EGYT-2509, chlorpromazine and haloperidol on the kidney function.
    Kövér G; Fekete M; Tost H; Szemerédi K
    Acta Physiol Hung; 1988; 72(3-4):321-33. PubMed ID: 3250211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain dopamine and behaviour. A critical analysis of the relationship between dopamine antagonism and therapeutic efficacy of neuroleptic drugs.
    Crow TJ; Gillbe C
    J Psychiatr Res; 1974; 11():163-72. PubMed ID: 4461788
    [No Abstract]   [Full Text] [Related]  

  • 12. Actions of dopaminergic agonists on cyclic AMP production in rat brain homogenates.
    Iversen LL; Horn AS; Miller RJ
    Adv Neurol; 1975; 9():197-212. PubMed ID: 167565
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of dopaminoceptor agonists and antagonists on the rat vas deferens "in vitro".
    Tayo FM
    West Afr J Pharmacol Drug Res; 1979; 5(1):45-53. PubMed ID: 555128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine agonist and antagonist activities of piribedil (ET495)and its metabolites.
    Costall B; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(1):71-81. PubMed ID: 4280019
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of the cardiovascular effects of haloperidol, thioridazine and chlorpromazine HCl.
    Brannan MD; Riggs JJ; Hageman WE; Pruss TP
    Arch Int Pharmacodyn Ther; 1980 Mar; 244(1):48-57. PubMed ID: 6251766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of dopamine receptor activity in dl-p-methoxyamphetamine- and d-amphetamine-induced locomotor activity.
    Tseng LF; Loh HH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):717-24. PubMed ID: 4858403
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence for involvement of dopamine in the action of diazepam: potentiation of haloperidol and chlorpromazine action in the brain.
    Rastogi RB; Lapierre YD; Singhal RL; Nair NP
    Adv Biochem Psychopharmacol; 1980; 24():283-9. PubMed ID: 6996443
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemistry of dopaminergic agonists.
    Cannon JG
    Adv Neurol; 1975; 9():177-83. PubMed ID: 1146652
    [No Abstract]   [Full Text] [Related]  

  • 19. Paradoxical effects of d-amphetamine on behavioral thermoregulation: possible mediation by brain dopamine.
    Yehuda S; Wurtman RJ
    J Pharmacol Exp Ther; 1974 Jul; 190(1):118-22. PubMed ID: 4367895
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of chlorpromazine, thioridazine and haloperidol on adrenergic transmitter mechanisms in man.
    Tuck JR
    Eur J Clin Pharmacol; 1973 Aug; 6(2):81-7. PubMed ID: 4358728
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.